# Treatment of Melasma With Yellow Light Compared to Tranexamic Acid

> **NCT05326997** · NA · TERMINATED · sponsor: **University of Nove de Julho** · enrollment: 21 (actual)

## Conditions studied

- Melasma

## Interventions

- **DEVICE:** Photobiomodulation group
- **OTHER:** Group control (Tranexamic acid)

## Key facts

- **NCT ID:** NCT05326997
- **Lead sponsor:** University of Nove de Julho
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Due to implementation challenges, we categorized this study as a pilot and ended data collection, intending to adapt methods for future trials. Although the initial sample size was 54, data from 21 participants were analyzed.
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05326997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05326997, "Treatment of Melasma With Yellow Light Compared to Tranexamic Acid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05326997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*